News

Industry news, company updates, and insights from DataM Intelligence. Stay informed with the latest developments in the industry.

Astorg Completes $1.075 Billion Acquisition of Thermo Fisher’s Microbiology Business

Astorg has completed the acquisition of Thermo Fisher Scientific’s microbiology business in a $1.075 billion transaction, creating new opportunities across clinical diagnostics, antimicrobial susceptibility testing, pharmaceutical microbiology and food safety testing. The deal highlights growing investor confidence in essential healthcare diagnostics infrastructure and microbiology-driven laboratory solutions.

Aug 13, 2026

India’s Biotechnology Ecosystem Accelerates as Biomedical Research Investment Strengthens Innovation and Healthcare Growth

India’s biotechnology sector is growing rapidly due to increased biomedical research investments, government innovation programs, healthcare technology advancements, and rising focus on life sciences research. Initiatives such as the Biomedical Research Career Programme Phase-III are strengthening scientific capabilities and creating new opportunities across biotechnology, biopharmaceuticals, diagnostics, and advanced healthcare solutions.

Aug 5, 2026

AI-Powered Healthcare in 2026: How Insight-Driven Patient Care Is Transforming Global Health Systems

Healthcare organizations worldwide are accelerating AI adoption to improve patient outcomes, optimize clinical workflows, and transition from reactive treatment models to proactive, personalized care. Industry experts identify predictive analytics, behavioral intelligence, and patient-centric digital engagement as the key forces driving healthcare transformation in 2026.

Aug 2, 2026

AI Market Boom Drives Healthcare Investment Diversification Across Latin America and the UK

Healthcare investment is expanding beyond traditional technology markets as investors seek diversification opportunities driven by artificial intelligence adoption, digital transformation, and healthcare innovation. Latin America and the UK are emerging as attractive healthcare investment destinations due to increasing demand for digital health solutions, AI-powered medical technologies, and advanced healthcare infrastructure.

Jul 30, 2026

UAE Expands Medical Robotics to Strengthen AI-Driven Healthcare System

The UAE is accelerating its healthcare transformation strategy by expanding medical robotics and artificial intelligence adoption across hospitals and healthcare facilities. The integration of robotic surgery, AI-enabled diagnostics, and smart healthcare technologies is positioning the country as a regional leader in next-generation medical innovation.

Jul 29, 2026

Samsung Launches AI-Powered Health Assistant Beta, Advancing the Future of Personalized Digital Healthcare

Samsung has launched Health Assistant Beta, its first fully integrated AI-powered personal health assistant within the Samsung Health ecosystem. The new platform leverages artificial intelligence to connect health data across sleep, activity, nutrition, mindfulness, and vital metrics, providing users with personalized wellness guidance and actionable health insights. The launch reflects Samsung's broader strategy to accelerate AI-driven preventive healthcare and strengthen its position in the rapidly expanding digital health market.

Jul 27, 2026

Pearl Health Raises $110 Million to Scale Medicare AI Platform and Advance Value-Based Care Innovation

Pearl Health has secured $110 million in new funding to accelerate the expansion of its AI-driven Medicare care platform. The investment will support healthcare providers with advanced analytics, value-based care tools, and patient management solutions aimed at improving outcomes while reducing healthcare costs.

Jul 25, 2026

CARPL.ai Raises $10 Million to Accelerate Global Adoption of AI-Powered Radiology Solutions

CARPL.ai, a global radiology artificial intelligence marketplace, has raised $10 million in Series A funding led by International Finance Corporation (IFC) to expand AI-powered medical imaging adoption, strengthen healthcare partnerships, and accelerate enterprise AI deployment across global healthcare systems.

Jul 24, 2026

From Refinery Ruins to Life Sciences Powerhouse: Philadelphia’s Bellwether District Attracts $450M Biotech Investment

Philadelphia’s former oil refinery site is undergoing a major transformation into a next-generation life sciences and advanced manufacturing ecosystem. TerraPower Isotopes, backed by Bill Gates-founded TerraPower, plans to invest $450 million in a new medical isotope production facility, signaling growing momentum for brownfield redevelopment and biotech infrastructure investment in the United States.

Jul 16, 2026